Teladoc Health to Announce First-Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/2/2026
- Wall St mixed as investors assess softer jobs data
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil falls to four-month low as US, Iran conclude talks in Doha
- Rivian stock jumps 5% on raised delivery outlook
- Analysis-Excommunications show a Pope Leo unafraid of making firm decisions
- Whirlpool to close Mexico plant, expects $165M restructuring cost
- Meta Platforms stock surges 8% on cloud business plans
- Canaccord Starts Infleqtion, Inc (INFQ) at Buy
- Wall Street ends choppy session lower as tech shares drop
Needham & Company Starts Teladoc (TDOC) at Buy
April 15, 2021 5:38 AM EDTNeedham & Company analyst Ryan MacDonald initiates coverage on Teladoc (NYSE: TDOC) with a Buy rating and a price target of $235.00.
The analyst comments "While Teladoc's market-leading position placed the company in a prime position to benefit from the pandemic-driven surge in adoption of... More
